Bibliografía del artículo
1. Programa Especial para Investigación y Capacitación en Enfermedades Tropicales (TDR), Organización Mundial de la Salud. Dengue. Guías para el diagnóstico, tratamiento, prevención y control; 2009. p. 3. Fecha de consulta: enero 24 de 2011. Disponible en:
http://whqlibdoc.who.int/publications/2009/9789995479213_spa.pdf
2. Instituto Nacional de Salud. Estadística en Salud Pública. Vigilancia rutinaria. Fecha de consulta: 06 de abril 2011. Disponible en: http://www.ins.gov.co/?idcategoria=85465#
3. Instituto Nacional de Salud. Colombia. Boletín N.° 29 de Vigilancia Epidemia por Dengue en Colombia. Fecha de consulta: 23 de agosto 2010. Disponible en: http://new.paho.org/col/index.php?option=com_content&task=view&id=810&Itemid=468.
4. Balmaseda A, Hammond SN, Pérez L et al. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74:449-56, 2006.
5. Kumaria R. Correlation of disease spectrum among four Dengue serotypes: a five years hospital based study from India. Braz J Infect Dis 14:141-6, 2010.
6. Rosen L. The Emperor's new clothes revisited or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg 26:337-43, 1997.
7. Ricco-Hesse R, Harrison LM, Salas RA et al. Origins of dengue type 2 viruses associated with increased pathogenecity in the Americas. Virology 230:244-51, 1997.
8. Murgue B, Roche C, Chungue E, Deparis, X. Prospective study of the duration and magnitude of viraemia in children hospitalized during the 1996–1997 dengue-2 outbreak in French Polynesia. J. Med. Virol 60:432-38, 2000.
9. Halstead SB. Pathogenesis of dengue. Challenges to molecular biology. Science 238:476-81, 1998.
10. Rothman AL. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 338:83-98, 2010.
11. Hatch S, Endy TP, Thomas S et al. Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis 203:1282-91, 2011.
12. Tang Y, Kou Z, Zhang F et al. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One5(12):e15631, 2010.
13. Priyadarshini D, Gadia RR, Tripathy A et al. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5(1):e8709, 2010.
14. Levy A, Valero N, Espina LM, Añez G, Arias J, Mosquera J. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg 104:16-23, 2010.
15. Restrepo BN, Isaza DM, Salazar CL, Ramírez R, Ospina M, Álvarez LG. Serum levels of IL-6, TNF- and IFN- ? in infants with and without dengue. Rev Soc Bras Med Trop 41:6-10, 2008.
16. Hober D, Poli L, Roblin B et al. Serum levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) in dengue-infected patients. Am J Trop Med Hyg 48:324-31, 1993.
17. Bravo JR, Guzman MG, Kouri G. Why dengue haemorrhagic fever in Cuba? Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 81:816-20, 1987.
18. Guzman MG, Kouri GP, Vazquez S, Rosario D, Bravo JR, Valdez L. DHF epidemics in Cuba, 1981 and 1987: Some interesting observations. Dengue Bull WHO 23: 39-43, 1999.
19. De la Sierra B, Kouri G, Guzmán MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152:533-542, 2007.
20. Blanton RE, Silva LK, Morato VG. Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. Eur J Hum Genet 16:762-65, 2008.
21. Perret C, Chanthavanich P, Pengsaa K et al. Dengue infection during pregnancy and transplacental antibody transfer in Thai mothers. J Infect 51:287-93, 2005.
22. McGready R, Ashley EA, Wuthiekanun V et al. Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border. PLoS Negl Trop Dis 16;4(11):e888, 2010.
23. Figueiredo LT, Carlucci RH, Duarte G. Estudo prospectivo com lactantes cujas maes tiveram dengue durante a gravidez. Rev Inst Med trop Sao Paulo 36: 417-21, 1994.
24. Fernández R, Rodríguez T, Borbonet F, Vázquez S, Guzmán MG, Kouri G. Estudio de la relación dengue-embarazo en un grupo de madres cubanas. Rev Cubana Med Trop 46:76-8, 1994.
25. Carles G, Talarmin A, Peneau C, Bertsch M. Dengue fever and pregnancy. A study of 38 cases in french Guiana. J Gynecol Obstet Biol Reprod. 2000; 29:758-62.
26. Ismail NA, Kampan N, Mahdy ZA, Jamil MA, Razi ZR. Dengue in pregnancy. Southeast Asian J Trop Med Public Health 37:681-3, 2006.
27. Restrepo BN, Isaza DM, Salazar CL et al. Efectos del virus del dengue durante el embarazo. Medellín, Colombia. Infectio 6:197-203, 2002.
28. Restrepo BN, Isaza DM, Salazar CL et al. Prenatal and postnatal effects of dengue infection during pregnancy. Biomédica 23:416-27, 2003.
29. Kariyawasam S, Senanayake H. Dengue infections during pregnancy: case series from a tertiary care hospital in Sri Lanka. J Infect Dev Ctries 24; 4:767-75, 2010.
30. Chye JK, Lim CT, Ng KB, Lim JM, George R, Lam SK. Vertical transmission of dengue. Clin Infect Dis 25:1374-7, 1997.
31. Chotigeat U, Kalayanarooj S, Nisalak A. Vertical transmission of dengue infection in Thai infants: two case reports. J Med Assoc Thai 86 Suppl 3: S628-32, 2003.
32. Carroll ID, Toovey S, Van Gompel A. Dengue fever and pregnancy – a review and comment. Travel Med Infect Dis 5:183-8, 2007.
33. Berberian G, Fariña D, Rosanova MT et al. Perinatal dengue infection. Arch Argent Pediatr 109(3):232-6, 2011.
34. Martínez E, Guzmán MG, Valdés M, Soler M, Kourí G. Dengue fever and hemorrhagic dengue in infants with a primary infection. Rev Cubana Med Trop 45(2):97-101, 1993.
35. Organización Panamericana de la Salud. Dengue y Dengue Hemorrágico en las Américas: Guías para su prevención y control. Publicación Científica N.° 578, 1995.
36. Gubler DJ, Kuno G, Sather GE, Velez M, Oliver A. Use of mosquito cell cultures and specific monoclonal antibodies for routine surveillance of dengue viruses. Am J Trop Med Hyg 33:158-65, 1984.
37. Guzman MG, Kouri G. Advances in dengue diagnosis. Clin Diagn Lab Inmunol 3:621-7, 1996.
38. Lanciotti RS, Calisher CH, Gubler DJ et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.J Clin Microbiol 30:545-51, 1992.
39. Seabright MA. Rapid banding technique for human chromosomes. Lancet 2: 971-72, 1971.
40. Fisher AM, Cockwell AE, Moore KJ et al. Rapid in situ harvesting and cytogenetic analysis of perinatal tissues samples. Prenat Diagn 16: 615-21, 1996.
41. Ministerio de la Protección Social, Dirección General de Salud Pública. Norma Técnica para la Detección Temprana de las Alteraciones del Crecimiento y Desarrollo en el Menor de 10 Años. Fecha de consulta: noviembre 15 de 2011. Disponible en:
http://www.esecarmenemiliaospina.gov.co/portal/UserFiles/File/evaluacion/guia%20de%20deteccion%20temprana%20en%20crecimiento%20y%20desarrollo.pdf
42. Pouliot SH, Xiong X, Harville E et al. Maternal dengue and pregnancy outcomes: a systematic review. Obstet Gynecol Surv 65(2):107-18, 2010.
43. Adam I, Jumaa AM, Elbashir HM, Karsany MS. Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan.Virol J 7:153, 2010.
44. Basurko C, Carles G, Youssef M, Guindi WE. Maternal and fetal consequences of dengue fever during pregnancy. Eur J Obstet Gynecol Reprod Biol 147:29-32, 2009.
45. Waduge R, Malavige G, Pradeepan M et al. Dengue infections during pregnancy, a case series from Sri Lanka and review of literature. J Clin Virol 37:27-33, 2006.
46. Tan PC, Rajasingam G, Devi S, Omar SZ. Dengue infection in pregnancy: prevalence, vertical transmission, and pregnancy outcome. Obstet Gynecol 111:1111-7, 2008.
47. Thaithumyanon P, Thisyakorn U, Deerojnawong J, Innis BL. Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman. Clin Infect Dis 18:248-9, 1994.
48. Bunyavejchevin S, Tanawattanacharoen S, Taechakraichana N, Thisyakorn U, Tannirandorn T, Limpaphayom K. Dengue hemorrhagic fever during pregnancy: antepartum, intrapartum and postpartum management. J Obstet Gynaecol Res 23:445-8, 1997.
49. Kerdpanich A, Watanaveeradej V, Samakoses R et al. Perinatal dengue infection. Southeast Asian J Trop Med Public Health 32:488-93, 2001.
50. Tagore S, Yim CF, Kwek K. Dengue haemorrhagic fever complicated by eclampsia in pregnancy. Singapore Med J 48(10):e281-3, 2007.
51. Chong KY, Lin KC. A preliminary report of the fetal effects of dengue infection in pregnancy. Gaoxiong Yi Xue Ke Xue Za Zhi 5:31-4, 1989.
52. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38:411-19, 1988.
53. Watanaveeradej V, Endy TP, Samakoses R et al. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg 69:123-8, 2003.
54. Phupong V. Dengue fever in pregnancy: a case report. BMC Pregnancy Childbirth 1:7, 2001.
55. Juffrie M, Meer GM, Hack CE y col. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 65:70-5, 2001.
56. Kurane I, Innis BL, Nimmannitya S y col. Activation of T Lymphocytes in Dengue Virus Infections. High Levels of Soluble Interleukin 2 Receptor, Soluble CD4, Soluble CD8, Interleukin 2 and Interferon gamma in Sera in Children with Dengue. J Clin Invest 88:1473-80, 1991.